Advanced Imaging Reveals Persistent Cardiac and⁣ Lung Abnormalities in Long COVID Patients

New research utilizing elegant cardiopulmonary imaging techniques has identified significant cardiac and lung abnormalities, ⁢vascular injury, and inflammation in individuals experiencing long COVID, even months after their initial infection. The⁢ findings‍ underscore‍ the potential for long-term health consequences following COVID-19 ⁤and highlight the need for increased clinical awareness and further investigation.

Understanding the Lingering Impact of Long COVID

The COVID-19 pandemic ⁤has profoundly impacted global health, with hundreds of millions infected worldwide.In the United States‍ alone, over 80 million cases and approximately ‍one million deaths have been recorded. Beyond the acute phase of the illness, a significant ⁤portion of recovered patients, estimated between ⁢one-third and two-thirds, continue to suffer from persistent symptoms months later, a condition now widely recognized as Long COVID.

“Unluckily, the long-term consequences of long COVID remain unknown,” stated Maria Giovanna Trivieri, MD, PhD, ⁢FACC, FRCPC, associate professor of medicine (cardiology) and associate professor of radiology at the Icahn School of Medicine. “In this study,we sought to use advanced cardiopulmonary imaging to assess for evidence of cardiac and lung abnormalities,vascular injury,and inflammation in patients with long COVID.”

Study Design and ⁢Methodology

To address this critical knowledge gap, researchers⁤ conducted a complete study involving 98 patients who had a history of COVID-19 infection and presented with persistent cardiopulmonary symptoms nine to 12 months post-infection, consistent with a diagnosis of Long COVID. A control group was also⁣ established, comprising individuals with a history of severe COVID-19 but without ongoing cardiopulmonary symptoms at the time of recruitment.both the Long COVID cohort and the control group underwent advanced imaging assessments,⁣ including cardiopulmonary 18F-FDG ⁤PET/MRI and⁤ dual-energy CT (DECT) of the lungs. Additionally, a subgroup of patients provided ‍plasma samples for protein analysis.

Key Findings: Evidence of⁤ Widespread Inflammation and Injury

The results of the advanced imaging revealed a striking prevalence of abnormalities in⁢ the Long COVID group.

PET/MRI Abnormalities: Fifty-seven percent of subjects in the Long COVID group showed abnormalities on PET/MRI scans. These included evidence of myocardial (heart muscle), pericardial (sac around the heart), periannular (around ⁤the valves), and vascular uptake, indicating inflammation and injury. Crucially, none of these abnormalities were detected in the PET/MR scans of the control group.
DECT Findings: Ninety percent of the Long COVID patients exhibited abnormalities on‍ DECT scans, with findings such as pulmonary infiltrates (areas of lung tissue that appear ⁤denser than normal)⁢ and abnormal perfusion (blood flow to ⁢the lungs).
Plasma Protein Analysis: ⁣The analysis of plasma protein concentrations revealed significant differences between the Long COVID and control groups. Furthermore,distinct plasma protein profiles were observed among Long COVID ⁣patients who had abnormal versus normal PET/MR scans,suggesting ‍a potential ⁤link between specific protein markers and the extent ‍of cardiac and lung damage.
long-Term Prognostic Value: Over a four-year follow-up period, ⁢PET/MR abnormalities were found to‍ be more frequent in patients who later developed heart failure, mitral regurgitation (a ⁢leaky heart valve), and pulmonary hypertension (high⁢ blood ⁢pressure in the lungs). This ‍suggests that these imaging findings may serve as early indicators of future cardiovascular complications.

Clinical Implications and Future Directions

The study’s findings carry significant implications for clinical practice and patient care.

“the results of the study shoudl raise awareness in the clinicians to elicit a proper history‍ that includes prior COVID infection and long COVID symptoms,” emphasized Ana Devesa, MD, PhD, former postdoctoral fellow at the Biomedical and Molecular Imaging Institute and group leader⁣ at the Centro Nacional de Investigaciones Cardiovasculares (CNIC). “If a temporal link is identified between⁣ symptoms and timing‍ of infection, further evaluation might be appropriate.”

These findings highlight the importance of a thorough patient history, specifically inquiring about prior COVID-19 infection and any persistent symptoms.For individuals with a history of COVID-19 ⁣and ongoing cardiopulmonary complaints, further diagnostic ⁤evaluation, potentially including advanced imaging, may be warranted to identify and manage potential long-term sequelae. Continued research is essential ⁣to fully understand the mechanisms underlying Long COVID and to develop effective diagnostic and therapeutic strategies.For more facts, visit www.snmmi.org.